Skip to content
1887

Abstract

Diabetes mellitus is a complex metabolic disorder and one of the fastest-growing global public health concerns. The gut microbiota is implicated in the pathophysiology of various diseases, including diabetes. This study utilized 16S rRNA metagenomic data from a volunteer citizen science initiative to investigate microbial markers associated with diabetes status (positive or negative) and type (type 1 or type 2 diabetes mellitus) using supervised machine learning (ML) models. The diversity of the microbiome varied according to diabetes status and type. Differential microbial signatures between diabetes types and negative group revealed an increased presence of , , , , and in subjects with diabetes type 1, and , and the order in subjects with diabetes type 2. The decision tree, elastic net, random forest (RF) and support vector machine with radial kernel ML algorithms were trained to screen and type diabetes based on microbial profiles of 76 subjects with type 1 diabetes, 366 subjects with type 2 diabetes and 250 subjects without diabetes. Using the 1000 most variable features, tree-based models were the highest-performing algorithms. The RF screening models achieved the best performance, with an average area under the receiver operating characteristic curve (AUC) of 0.76, although all models lacked sensitivity. Reducing the dataset to 500 features produced an AUC of 0.77 with sensitivity increasing by 74% from 0.46 to 0.80. Model performance improved for the classification of negative-status and type 2 diabetes. Diabetes type models performed best with 500 features, but the metric performed poorly across all model iterations. ML has the potential to facilitate early diagnosis of diabetes based on microbial profiles of the gut microbiome.

Funding
This study was supported by the:
  • National Institute of Biological Resources (Award NIBR202402201)
    • Principal Award Recipient: ApplicableNot
  • Korea Health Industry Development Institute (Award RS-2024-00406488)
    • Principal Award Recipient: ApplicableNot
  • National Research Foundation (KR) (Award RS-2024-00456300)
    • Principal Award Recipient: ApplicableNot
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License. This article was made open access via a Publish and Read agreement between the Microbiology Society and the corresponding author’s institution.
Loading

Article metrics loading...

/content/journal/mgen/10.1099/mgen.0.001365
2025-03-10
2026-01-22

Metrics

Loading full text...

Full text loading...

/deliver/fulltext/mgen/11/3/mgen001365.html?itemId=/content/journal/mgen/10.1099/mgen.0.001365&mimeType=html&fmt=ahah

References

  1. Cole JB, Florez JC. Genetics of diabetes mellitus and diabetes complications. Nat Rev Nephrol 2020; 16:377–390 [View Article] [PubMed]
    [Google Scholar]
  2. Zimmet PZ, Magliano DJ, Herman WH, Shaw JE. Diabetes: a 21st century challenge. Lancet Diabetes Endocrinol 2014; 2:56–64 [View Article]
    [Google Scholar]
  3. Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K et al. IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract 2022; 183:109119 [View Article] [PubMed]
    [Google Scholar]
  4. Chaki J, Thillai Ganesh S, Cidham SK, Ananda Theertan S. Machine learning and artificial intelligence based diabetes mellitus detection and self-management: a systematic review. J King Saud Univ - Comput Inf Sci 2022; 34:3204–3225 [View Article]
    [Google Scholar]
  5. Rodrigues Oliveira SM, Rebocho A, Ahmadpour E, Nissapatorn V, de Lourdes Pereira M. Type 1 diabetes mellitus: a review on advances and challenges in creating insulin-producing devices. Micromachines 2023; 14:151 [View Article] [PubMed]
    [Google Scholar]
  6. Dludla PV, Mabhida SE, Ziqubu K, Nkambule BB, Mazibuko-Mbeje SE et al. Pancreatic β-cell dysfunction in type 2 diabetes: implications of inflammation and oxidative stress. World J Diabetes 2023; 14:130–146 [View Article] [PubMed]
    [Google Scholar]
  7. Matheus AS de M, Tannus LRM, Cobas RA, Palma CCS, Negrato CA et al. Impact of diabetes on cardiovascular disease: an update. Int J Hypertens 2013; 2013:653789 [View Article] [PubMed]
    [Google Scholar]
  8. Farsani SF, Souverein PC, Vorst MMJ van der, Knibbe CAJ, Boer A de et al. Chronic comorbidities in children with type 1 diabetes: a population-based cohort study. Arch Dis Child 2015; 100:763–768 [View Article]
    [Google Scholar]
  9. Cai X, Li J, Cai W, Chen C, Ma J et al. Meta-analysis of type 1 diabetes mellitus and risk of cardiovascular disease. J Diabetes Complicat 2021; 35:107833 [View Article]
    [Google Scholar]
  10. Lu C-L, Shen H-N, Hu SC, Wang J-D, Li C-Y. A population-based study of all-cause mortality and cardiovascular disease in association with prior history of hypoglycemia among patients with type 1 diabetes. Diabetes Care 2016; 39:1571–1578 [View Article] [PubMed]
    [Google Scholar]
  11. Kong APS, Xu G, Brown N, So W-Y, Ma RCW et al. Diabetes and its comorbidities--where East meets West. Nat Rev Endocrinol 2013; 9:537–547 [View Article] [PubMed]
    [Google Scholar]
  12. Masters SL, Latz E, O’Neill LAJ. The inflammasome in atherosclerosis and type 2 diabetes. Sci Transl Med 2011; 3:81ps17 [View Article] [PubMed]
    [Google Scholar]
  13. Dash NR, Al Bataineh MT, Alili R, Al Safar H, Alkhayyal N et al. Functional alterations and predictive capacity of gut microbiome in type 2 diabetes. Sci Rep 2023; 13:22386 [View Article] [PubMed]
    [Google Scholar]
  14. Bäckhed F, Ding H, Wang T, Hooper LV, Koh GY et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA 2004; 101:15718–15723 [View Article]
    [Google Scholar]
  15. Singer-Englar T, Barlow G, Mathur R. Obesity, diabetes, and the gut microbiome: an updated review. Expert Rev Gastroenterol Hepatol 2019; 13:3–15 [View Article]
    [Google Scholar]
  16. Lu J, Ma KL, Ruan XZ. Dysbiosis of gut microbiota contributes to the development of diabetes mellitus. Infect Microbes Dis 2019; 1:43–48 [View Article]
    [Google Scholar]
  17. Vrieze A, Van Nood E, Holleman F, Salojärvi J, Kootte RS et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 2012; 143:913–6 [View Article] [PubMed]
    [Google Scholar]
  18. Ridaura VK, Faith JJ, Rey FE, Cheng J, Duncan AE et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science 2013; 341:1241214 [View Article] [PubMed]
    [Google Scholar]
  19. Gérard C, Vidal H. Impact of gut microbiota on host glycemic control. Front Endocrinol 2019; 10:29 [View Article] [PubMed]
    [Google Scholar]
  20. Topçuoğlu BD, Lesniak NA, Ruffin MT, Wiens J, Schloss PD. A framework for effective application of machine learning to microbiome-based classification problems. mBio 2020; 11:e00434-20 [View Article] [PubMed]
    [Google Scholar]
  21. Nomura A, Noguchi M, Kometani M, Furukawa K, Yoneda T. Artificial intelligence in current diabetes management and prediction. Curr Diab Rep 2021; 21:61 [View Article] [PubMed]
    [Google Scholar]
  22. Manandhar I, Alimadadi A, Aryal S, Munroe PB, Joe B et al. Gut microbiome-based supervised machine learning for clinical diagnosis of inflammatory bowel diseases. Am J Physiol Gastrointest Liver Physiol 2021; 320:G328–G337 [View Article] [PubMed]
    [Google Scholar]
  23. Lupolova N, Lycett SJ, Gally DL. A guide to machine learning for bacterial host attribution using genome sequence data. Microb Genom 2019; 5:e000317 [View Article] [PubMed]
    [Google Scholar]
  24. McDonald D, Hyde E, Debelius JW, Morton JT, Gonzalez A et al. American gut: an open platform for citizen science microbiome research. mSystems 2018; 3:00031–18
    [Google Scholar]
  25. McDonald D, Kaehler B, Gonzalez A, DeReus J, Ackermann G et al. redbiom: a rapid sample discovery and feature characterization system. mSystems 2019; 4: [View Article]
    [Google Scholar]
  26. Gonzalez A, Navas-Molina JA, Kosciolek T, McDonald D, Vázquez-Baeza Y et al. Qiita: rapid, web-enabled microbiome meta-analysis. Nat Methods 2018; 15:796–798 [View Article] [PubMed]
    [Google Scholar]
  27. Bolyen E, Rideout JR, Dillon MR, Bokulich NA, Abnet CC et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat Biotechnol 2019; 37:852–857 [View Article]
    [Google Scholar]
  28. Amir A, McDonald D, Navas-Molina JA, Kopylova E, Morton JT et al. Deblur rapidly resolves single-nucleotide community sequence patterns. mSystems 2017; 2: [View Article]
    [Google Scholar]
  29. McDonald D, Price MN, Goodrich J, Nawrocki EP, DeSantis TZ et al. An improved greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea. ISME J 2012; 6:610–618 [View Article] [PubMed]
    [Google Scholar]
  30. Bokulich NA, Kaehler BD, Rideout JR, Dillon M, Bolyen E et al. Optimizing taxonomic classification of marker-gene amplicon sequences with QIIME 2’s q2-feature-classifier plugin. Microbiome 2018; 6:90 [View Article]
    [Google Scholar]
  31. Segata N, Izard J, Waldron L, Gevers D, Miropolsky L et al. Metagenomic biomarker discovery and explanation. Genome Biol 2011; 12:R60 [View Article] [PubMed]
    [Google Scholar]
  32. Liu C, Cui Y, Li X, Yao M. microeco: an R package for data mining in microbial community ecology. FEMS Microbiol Ecol 2021; 97:fiaa255 [View Article] [PubMed]
    [Google Scholar]
  33. McMurdie PJ, Holmes S. phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data. PLoS One 2013; 8:e61217 [View Article] [PubMed]
    [Google Scholar]
  34. Aryal S, Alimadadi A, Manandhar I, Joe B, Cheng X. Machine learning strategy for gut microbiome-based diagnostic screening of cardiovascular disease. Hypertension 2020; 76:1555–1562 [View Article] [PubMed]
    [Google Scholar]
  35. Kuhn M. Building predictive models in R using the caret package. J Stat Softw 2008; 28:1–26 [View Article]
    [Google Scholar]
  36. Galaviz KI, Narayan KMV, Lobelo F, Weber MB. Lifestyle and the prevention of type 2 diabetes: a status report. Am J Lifestyle Med 2018; 12:4–20 [View Article] [PubMed]
    [Google Scholar]
  37. Rawat V, Joshi S, Gupta S, Singh DP, Singh N. Machine learning algorithms for early diagnosis of diabetes mellitus: a comparative study. Mater Today 2022; 56:502–506 [View Article]
    [Google Scholar]
  38. Kitten AK, Ryan L, Lee GC, Flores BE, Reveles KR. Gut microbiome differences among Mexican Americans with and without type 2 diabetes mellitus. PLoS One 2021; 16:e0251245 [View Article] [PubMed]
    [Google Scholar]
  39. Han JH, Yoon SJ, Lee HS, Park G, Lim J et al. Application of machine learning approaches to predict postnatal growth failure in very low birth weight infants. Yonsei Med J 2022; 63:640–647 [View Article] [PubMed]
    [Google Scholar]
  40. Kim J, Choi YH, Yoon H, Lim HJ, Han JW et al. Prediction of high-risk neuroblastoma among neuroblastic tumors using radiomics features derived from magnetic resonance imaging: a pilot study. Yonsei Med J 2024; 65:293–301 [View Article] [PubMed]
    [Google Scholar]
  41. Guo S, Zhang H, Chu Y, Jiang Q, Ma Y. A neural network-based framework to understand the type 2 diabetes-related alteration of the human gut microbiome. Imeta 2022; 1:e20 [View Article] [PubMed]
    [Google Scholar]
  42. Gou W, Ling C-W, He Y, Jiang Z, Fu Y et al. Interpretable machine learning framework reveals robust gut microbiome features associated with type 2 diabetes. Diabetes Care 2021; 44:358–366 [View Article] [PubMed]
    [Google Scholar]
  43. Xu W, Wang T, Wang N, Zhang H, Zha Y et al. Artificial intelligence-enabled microbiome-based diagnosis models for a broad spectrum of cancer types. Brief Bioinformatics 2023; 24:bbad178 [View Article]
    [Google Scholar]
  44. Douglas GM, Hansen R, Jones CMA, Dunn KA, Comeau AM et al. Multi-omics differentially classify disease state and treatment outcome in pediatric Crohn’s disease. Microbiome 2018; 6:13 [View Article] [PubMed]
    [Google Scholar]
  45. Lauss M, Visne I, Kriegner A, Ringnér M, Jönsson G et al. Monitoring of technical variation in quantitative high-throughput datasets. Cancer Inform 2013; 12:193–201 [View Article] [PubMed]
    [Google Scholar]
  46. Amir A, McDonald D, Navas-Molina JA, Debelius J, Morton JT et al. Correcting for microbial blooms in fecal samples during room-temperature shipping. mSystems 2017; 2: [View Article]
    [Google Scholar]
  47. Zhang X, Sandhu A, Edirisinghe I, Burton-Freeman B. Microbiome, pre-diabetes, and polyphenol metabolites: insights and interactions in humans after a 4-week dietary intervention with red raspberries and prebiotics. Curr Dev Nutr 2020; 4:nzaa045 [View Article]
    [Google Scholar]
  48. Zhang L, Wang Z, Zhang X, Zhao L, Chu J et al. Alterations of the gut microbiota in patients with diabetic nephropathy. Microbiol Spectr 2022; 10:e00324–22 [View Article]
    [Google Scholar]
  49. Maskarinec G, Raquinio P, Kristal BS, Setiawan VW, Wilkens LR et al. The gut microbiome and type 2 diabetes status in the multiethnic cohort. PLoS One 2021; 16:e0250855 [View Article] [PubMed]
    [Google Scholar]
  50. Tamanai-Shacoori Z, Smida I, Bousarghin L, Loreal O, Meuric V et al. Roseburia spp.: a marker of health?. Future Microbiol 2017; 12:157–170 [View Article] [PubMed]
    [Google Scholar]
  51. Yang H-T, Liu J-K, Xiu W-J, Tian T-T, Yang Y et al. Gut microbiome-based diagnostic model to predict diabetes mellitus. Bioengineered 2021; 12:12521–12534 [View Article] [PubMed]
    [Google Scholar]
  52. Ejtahed H-S, Hoseini-Tavassol Z, Khatami S, Zangeneh M, Behrouzi A et al. Main gut bacterial composition differs between patients with type 1 and type 2 diabetes and non-diabetic adults. J Diabetes Metab Disord 2020; 19:265–271 [View Article] [PubMed]
    [Google Scholar]
  53. Leiva-Gea I, Sánchez-Alcoholado L, Martín-Tejedor B, Castellano-Castillo D, Moreno-Indias I et al. Gut microbiota differs in composition and functionality between children with type 1 diabetes and MODY2 and healthy control subjects: a case-control study. Diabetes Care 2018; 41:2385–2395 [View Article] [PubMed]
    [Google Scholar]
  54. Moreno-Indias I, Cardona F, Tinahones FJ, Queipo-Ortuño MI. Impact of the gut microbiota on the development of obesity and type 2 diabetes mellitus. Front Microbiol 2014; 5: [View Article]
    [Google Scholar]
  55. Martínez-López YE, Esquivel-Hernández DA, Sánchez-Castañeda JP, Neri-Rosario D, Guardado-Mendoza R et al. Type 2 diabetes, gut microbiome, and systems biology: a novel perspective for a new era. Gut Microbes 2022; 14:2111952 [View Article] [PubMed]
    [Google Scholar]
  56. Somasundaram SK, Alli P. A machine learning ensemble classifier for early prediction of diabetic retinopathy. J Med Syst 2017; 41:201 [View Article] [PubMed]
    [Google Scholar]
  57. Allaband C, McDonald D, Vázquez-Baeza Y, Minich JJ, Tripathi A et al. Microbiome 101: studying, analyzing, and interpreting gut microbiome data for clinicians. Clin Gastroenterol Hepatol 2019; 17:218–230 [View Article] [PubMed]
    [Google Scholar]
  58. Lambeth SM, Carson T, Lowe J, Ramaraj T, Leff JW et al. Composition, diversity, and abundance of gut microbiome in prediabetes and type 2 diabetes. J Diabetes Obes 2015; 2:1–7 [View Article] [PubMed]
    [Google Scholar]
  59. Farquad MAH, Bose I. Preprocessing unbalanced data using support vector machine. Decis Support Syst 2012; 53:226–233 [View Article]
    [Google Scholar]
/content/journal/mgen/10.1099/mgen.0.001365
Loading
/content/journal/mgen/10.1099/mgen.0.001365
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF

Supplementary material 2

EXCEL
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An error occurred
Approval was partially successful, following selected items could not be processed due to error